ORBIMED ADVISORS LLC

Q4 2021 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
12/31/2021
Date filed
2/14/2022
Form type
13F-HR
Num holdings
159
Total value ($000)
$7,778,455
Net value change ($000)
-1,320,875 (-14.5%)
New positions
12
Sold out positions
23
Turnover %
13.2%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Theseus Pharmaceuticals, Inc. 213,514 NEW
PFE 154,439 NEW
ACET 73,544 129.7%
CMPX 68,608 NEW
BMRN 67,488 787.4%
Seagen Inc. 55,850 122.7%
Tricida, Inc. 53,676 120.3%
HCA 53,031 112.7%
SNDX 39,729 1090.9%
SYK 35,452 39.8%
Top Reduces (Value $000, Stocks/ETFs)
IVVD -191,219 -84.1%
PRLD -188,746 -60.2%
MRK -143,975 -51.4%
ELV -77,207 -100.0%
Deciphera Pharmaceuticals, Inc. -74,183 -100.0%
PGNY -71,123 -100.0%
CRSP -68,580 -100.0%
Gracell Biotechnologies Inc. -61,738 -56.5%
Turning Point Therapeutics, Inc. -56,385 -35.9%
ImmunoGen, Inc. -55,765 -66.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410